TRAF6 and IRF7 control HIV replication in macrophages

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Sirois, Mélissa ^a   Robitaille, Lynda ^a   Allary, Robin ^a   Shah, Mohak ^b   Woelk, Christopher H ^c   Estaquier, Jérôme ^a,d   Corbeil, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 7; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; GENE; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; TRAF6 GENE; UPREGULATION; VIRUS REPLICATION; VISA GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HIV-1; HUMANS; INTERFERON REGULATORY FACTOR-7; INTERFERON-ALPHA; MACROPHAGES; TIME FACTORS; TNF RECEPTOR-ASSOCIATED FACTOR 6; VIRUS REPLICATION;

EID: 82155188902     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028125     Document Type: Article

References (63)

1. Beutler B, Hoebe K, Du X, Ulevitch RJ, (2003) How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 74: 479-485.
2. Takeda K, Akira S, (2003) Toll receptors and pathogen resistance. Cell Microbiol 5: 143-153.
3. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD, (1989) Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J Exp Med 169: 1137-1151.
4. Meylan PR, Guatelli JC, Munis JR, Richman DD, Kornbluth RS, (1993) Mechanisms for the inhibition of HIV replication by interferons-alpha,-beta, and-gamma in primary human macrophages. Virology 193: 138-148.
5. Pestka S, Langer JA, Zoon KC, Samuel CE, (1987) Interferons and their actions. Annu Rev Biochem 56: 727-777.
6. Samuel CE, (1988) Mechanisms of the antiviral action of interferons. Prog Nucleic Acid Res Mol Biol 35: 27-72.
7. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD, (1998) How cells respond to interferons. Annu Rev Biochem 67: 227-264.
8. Barr SD, Smiley JR, Bushman FD, (2008) The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog 4: e1000007.
9. Bishop KN, Holmes RK, Malim MH, (2006) Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J Virol 80: 8450-8458.
10. Jouvenet N, Neil SJ, Zhadina M, Zang T, Kratovac Z, et al. (2009) Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 83: 1837-1844.
11. Neil SJ, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
12. Peng G, Lei KJ, Jin W, Greenwell-Wild T, Wahl SM, (2006) Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med 203: 41-46.
13. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
14. Kunzi MS, Farzadegan H, Margolick JB, Vlahov D, Pitha PM, (1995) Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression. J Infect Dis 171: 822-828.
15. Muto NF, Martinand-Mari C, Adelson ME, Suhadolnik RJ, (1999) Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct. J Virol 73: 9021-9028.
16. Schroder HC, Ugarkovic D, Merz H, Kuchino Y, Okamoto T, et al. (1990) Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2′,5′-oligoadenylate synthetase hybrid gene. Faseb J 4: 3124-3130.
17. Izmailova E, Bertley FM, Huang Q, Makori N, Miller CJ, et al. (2003) HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat Med 9: 191-197.
18. Smith AJ, Li Q, Wietgrefe SW, Schacker TW, Reilly CS, et al. (2010) Host genes associated with HIV-1 replication in lymphatic tissue. J Immunol 185: 5417-5424.
19. Campillo-Gimenez L, Cumont MC, Fay M, Kared H, Monceaux V, et al. (2010) AIDS progression is associated with the emergence of IL-17-producing cells early after simian immunodeficiency virus infection. J Immunol 184: 984-992.
20. Medzhitov R, Janeway CA Jr, (2002) Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300.
21. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-737.
22. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, et al. (2004) Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5: 1061-1068.
23. Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, et al. (2009) TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS One 4: e5674.
24. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
25. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, et al. (2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175: 2851-2858.
26. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988.
27. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
28. Seth RB, Sun L, Ea CK, Chen ZJ, (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
29. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, et al. (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19: 727-740.
30. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, et al. (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4: 491-496.
31. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, et al. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151.
32. Laforge M, Campillo-Gimenez L, Monceaux V, Cumont MC, Hurtrel B, et al. (2011) HIV/SIV infection primes monocytes and dendritic cells for apoptosis. PLoS Pathog 7: e1002087.
33. Shah M, Corbeil J, (2011) A general framework for analyzing data from two short time-series microarray experiments. IEEE/ACM Trans Comput Biol Bioinform 8: 14-26.
34. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
35. Yoshida R, Takaesu G, Yoshida H, Okamoto F, Yoshioka T, et al. (2008) TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway. J Biol Chem 283: 36211-36220.
36. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, et al. (2003) Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 171: 4304-4310.
37. Lin R, Heylbroeck C, Pitha PM, Hiscott J, (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18: 2986-2996.
38. Marie I, Durbin JE, Levy DE, (1998) Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. Embo J 17: 6660-6669.
39. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T, et al. (1998) Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441: 106-110.
40. Sato M, Tanaka N, Hata N, Oda E, Taniguchi T, (1998) Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett 425: 112-116.
41. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, et al. (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1: 507-518.
42. Weaver BK, Kumar KP, Reich NC, (1998) Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol 18: 1359-1368.
43. Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, et al. (1998) Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. Embo J 17: 1087-1095.
44. Ning S, Pagano JS, Barber GN, (2011) IRF7: activation, regulation, modification and function. Genes Immun.
45. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
46. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, et al. (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548.
47. Buettner N, Vogt C, Martinez-Sobrido L, Weber F, Waibler Z, et al. (2010) Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor. J Gen Virol 91: 220-227.
48. Colina R, Costa-Mattioli M, Dowling RJ, Jaramillo M, Tai LH, et al. (2008) Translational control of the innate immune response through IRF-7. Nature 452: 323-328.
49. Oldak M, Tolzmann L, Wnorowski A, Podgorska MJ, Silling S, et al. (2011) Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7. J Virol 85: 178-188.
50. Sgarbanti M, Borsetti A, Moscufo N, Bellocchi MC, Ridolfi B, et al. (2002) Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J Exp Med 195: 1359-1370.
51. Sgarbanti M, Remoli AL, Marsili G, Ridolfi B, Borsetti A, et al. (2008) IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J Virol 82: 3632-3641.
52. Covic M, Hassa PO, Saccani S, Buerki C, Meier NI, et al. (2005) Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J 24: 85-96.
53. Ruland J, Duncan GS, Elia A, del Barco Barrantes I, Nguyen L, et al. (2001) Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 104: 33-42.
54. Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, et al. (2003) Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22: 3307-3318.
55. Genin P, Lin R, Hiscott J, Civas A, (2009) Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7. Mol Cell Biol 29: 3435-3450.
56. Fortin JF, Cantin R, Lamontagne G, Tremblay M, (1997) Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J Virol 71: 3588-3596.
57. Lambert AA, Gilbert C, Richard M, Beaulieu AD, Tremblay MJ, (2008) The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 112: 1299-1307.
58. Richman DD, Johnson VA, Mayers DM, Shirasaka T, O'Brien MC, et al. (2001) In vitro evaluation of experimental agents for anti-HIV activity. Curr Protoc Immunol Chapter 12: Unit 12 19.
59. Wu Z, Irizarry RA, (2005) Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Biol 12: 882-893.
60. Song L, Bedo J, Borgwardt KM, Gretton A, Smola A, (2007) Gene selection via the BAHSIC family of algorithms. Bioinformatics 23: i490-498.
61. Shah Mohak CJ, (2009) A General Framework for Analyzing Data from Two Short Time-Series Microarray Experiments. IEEE/ACM Transactions on Computational Biology and Bioinformatics IEEE computer Society Digital Library. IEEE Computer Society, 8: 14-26.
62. Chen H, Sharp BM, (2004) Content-rich biological network constructed by mining PubMed abstracts. BMC Bioinformatics 5: 147.
63. Nuovo GJ, Hohman RJ, Nardone GA, Nazarenko IA, (1999) In situ amplification using universal energy transfer-labeled primers. J Histochem Cytochem 47: 273-280.